Where does Medable Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medable Inc. ranks #48,630 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medable Inc. hold?

Medable Inc. holds 5 US utility patents granted between 2022 and 2024, spanning 3 technology areas.

What is Medable Inc.'s Innovation Score?

Medable Inc. has an Innovation Score of 43.2 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Medable Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Medable Inc..

What does claim depth mean for Medable Inc.'s patents?

Medable Inc.'s patents average 18.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medable Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Medable Inc.

Q: What technology areas does Medable Inc. focus on?

Medable Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 5 patents, ranking #941 of 3,149 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2022–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medable ranks #48,630 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#48,630
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.2/100): 18.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R48630 · US Corporation #48,630 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,630/49,997
PHOTO-FINISH Mebias Discovery
CPC-NARROW G16H · 3 areas
INNOV-PAR 43.2/100
CLAIMS-RICH 18.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2024 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Mebias Discovery, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medable’s 43.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (14%) Velocity 20.0 pts (46%) Breadth 6.1 pts (14%) Claim depth 10.9 pts (25%)

Qualcomm Incorporated · highest

85
Medable · this assignee

43
3D Lighting… · lowest

7

What this shows Medable's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medable?

Each dot is one of Medable’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medable’s own 18.2 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medable vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medable's grants concentrate

Medable Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2022. By volume, Medable sits between Mebias Discovery, Inc. and Media Links Co., Ltd..

Medable's three-year grant acceleration

Medable Inc. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mebias Discovery

5
Meccanotecnica S…

5
Mechadyne Interna…

5
Med-logics

5
Mederis Diabetes

5
Medicapture

5
Media Blast & Abr…

5
Media Links

5
Medable ◀

5

What this shows Medable holds 5 patents at rank #48,798, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medable

By rank, the assignees closest to #48,798 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Medable's primary technology class.

Medable's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Medable Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	20.0%
2023	3	60.0%
2024	1	20.0%

Which technologies does Medable Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

G06F - Electric Digital Data Processing 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medable Inc.'s patent record in context - here's where to go next.

Medable Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 100% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #48,630 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medable Inc. against Mebias Discovery, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.